dc.contributor.author | Cui, Guanglin | |
dc.date.accessioned | 2022-11-03T14:54:34Z | |
dc.date.available | 2022-11-03T14:54:34Z | |
dc.date.created | 2022-05-06T13:09:17Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Cui, G (2022) Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives. Biomedicine & Pharmacotherapy, 149, 112923. doi: | en_US |
dc.identifier.issn | 1950-6007 | |
dc.identifier.uri | https://hdl.handle.net/11250/3029978 | |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer : Strategies and perspectives | en_US |
dc.title.alternative | Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2022 The Author(s) | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 | en_US |
dc.source.pagenumber | 11 | en_US |
dc.source.volume | 149 | en_US |
dc.source.journal | Biomedicine & Pharmacotherapy | en_US |
dc.identifier.doi | 10.1016/j.biopha.2022.112923 | |
dc.identifier.cristin | 2022112 | |
dc.source.articlenumber | 112923 | en_US |